-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Theriva Biologics, Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from Q1 2022 to Q4 2023.
- Theriva Biologics, Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2023 was -$424K, a 24% increase year-over-year.
- Theriva Biologics, Inc. Income Tax Expense (Benefit) for the twelve months ending December 31, 2023 was -$1.64M, a 15.1% decline year-over-year.
- Theriva Biologics, Inc. annual Income Tax Expense (Benefit) for 2024 was $0.000.
- Theriva Biologics, Inc. annual Income Tax Expense (Benefit) for 2023 was -$1.64M, a 15.1% decline from 2022.
- Theriva Biologics, Inc. annual Income Tax Expense (Benefit) for 2022 was -$1.43M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)